These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22005597)

  • 1. Diminished conditioned responding to the nicotine stimulus by antidepressant drugs with differing specificity for the serotonin and norepinephrine transporter.
    Dion AM; Sanderson SC; Murrin LC; Bevins RA
    Pharmacol Biochem Behav; 2012 Jan; 100(3):419-24. PubMed ID: 22005597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.
    Andreasen JT; Redrobe JP
    Behav Brain Res; 2009 Jan; 197(1):150-6. PubMed ID: 18786574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Dekeyne A; Papp M; La Rochelle CD; MacSweeny C; Peglion JL; Brocco M
    J Pharmacol Exp Ther; 2001 Aug; 298(2):581-91. PubMed ID: 11454919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987.
    Andreasen JT; Redrobe JP; Nielsen EØ
    Pharmacol Biochem Behav; 2012 Jan; 100(3):624-9. PubMed ID: 22108649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reboxetine: attenuation of intravenous nicotine self-administration in rats.
    Rauhut AS; Mullins SN; Dwoskin LP; Bardo MT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):664-72. PubMed ID: 12388649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus.
    Murray JE; Bevins RA
    Eur J Pharmacol; 2007 Apr; 561(1-3):91-104. PubMed ID: 17343849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
    Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
    J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combined treatment with noradrenaline and serotonin reuptake inhibitors on conditioned freezing.
    Inoue T; Nakagawa S; Izumi T; Kitaichi Y; Koyama T
    Eur J Pharmacol; 2006 Jul; 540(1-3):91-5. PubMed ID: 16714013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment.
    Moeller O; Hetzel G; Rothermundt M; Michael N; Nyhuis PW; Suslow T; Arolt V; Erfurth A
    J Psychiatr Res; 2003; 37(3):261-2. PubMed ID: 12650745
    [No Abstract]   [Full Text] [Related]  

  • 10. Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?
    Filip M; Papla I
    Pol J Pharmacol; 2001; 53(6):577-85. PubMed ID: 11985331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical doses of citalopram or reboxetine differentially modulate passive and active behaviors of female Wistar rats with high or low immobility time in the forced swimming test.
    Flores-Serrano AG; Vila-Luna ML; Álvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL; Pineda JC
    Pharmacol Biochem Behav; 2013 Sep; 110():89-97. PubMed ID: 23769836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioned response evoked by nicotine conditioned stimulus preferentially induces c-Fos expression in medial regions of caudate-putamen.
    Charntikov S; Tracy ME; Zhao C; Li M; Bevins RA
    Neuropsychopharmacology; 2012 Mar; 37(4):876-84. PubMed ID: 22048468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
    Takahashi E; Katayama M; Niimi K; Itakura C
    Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conditional stimulus effects of nicotine vary as a function of training dose.
    Murray JE; Bevins RA
    Behav Pharmacol; 2007 Dec; 18(8):707-16. PubMed ID: 17989508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.
    Millan MJ; Dekeyne A
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):579-93. PubMed ID: 17076935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test.
    Andreasen JT; Nielsen EO; Redrobe JP
    Psychopharmacology (Berl); 2009 Aug; 205(3):517-28. PubMed ID: 19452140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.
    Popik P; Kozela E; Krawczyk M
    Br J Pharmacol; 2003 Jul; 139(6):1196-202. PubMed ID: 12871839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants differentially affect striatal amphetamine-stimulated dopamine and serotonin release in rats with high and low novelty-oriented behaviour.
    O'Leary A; Kõiv K; Raudkivi K; Harro J
    Pharmacol Res; 2016 Nov; 113(Pt B):739-746. PubMed ID: 26920253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus properties of antidepressant agents: a review.
    Dekeyne A; Millan MJ
    Behav Pharmacol; 2003 Sep; 14(5-6):391-407. PubMed ID: 14501253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.
    Wong EH; Sonders MS; Amara SG; Tinholt PM; Piercey MF; Hoffmann WP; Hyslop DK; Franklin S; Porsolt RD; Bonsignori A; Carfagna N; McArthur RA
    Biol Psychiatry; 2000 May; 47(9):818-29. PubMed ID: 10812041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.